Nerium oleander extract - Ozelle Pharmaceuticals

Drug Profile

Nerium oleander extract - Ozelle Pharmaceuticals

Alternative Names: Anvirzel; NOE - Ozelle Pharmaceuticals; Oleandrin - Ozelle Pharmaceuticals

Latest Information Update: 20 Jul 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Ozelle Pharmaceuticals
  • Class Antineoplastics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Solid tumours

Most Recent Events

  • 20 Jul 2011 No Development Reported - Phase-I for Solid tumours in USA (IM)
  • 23 Mar 2007 Development is ongoing in the US
  • 13 Apr 2000 Phase-I clinical trials in Solid tumours in USA (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top